To learn more about the pharmacology of pitavastatin by characterizing the dose-related effect and variability of the effect of pitavastatin on the surrogate marker: low-density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review.Secondary objectives
To characterize the dose-related effect and variability of effect of pitavastatin on the surrogate markers: total cholesterol, high-density lipoprotein (HDL cholesterol), and triglycerides.
To quantify the effect of various doses of pitavastatin on withdrawals due to adverse effects.
This is a protocol.